Mikko Siurala

1.3k total citations
26 papers, 986 citations indexed

About

Mikko Siurala is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Mikko Siurala has authored 26 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 24 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Mikko Siurala's work include Virus-based gene therapy research (24 papers), CAR-T cell therapy research (24 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Mikko Siurala is often cited by papers focused on Virus-based gene therapy research (24 papers), CAR-T cell therapy research (24 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Mikko Siurala collaborates with scholars based in Finland, United States and Netherlands. Mikko Siurala's co-authors include Akseli Hemminki, Riikka Havunen, Siri Tähtinen, Anna Kanerva, Suvi Sorsa, João M. Santos, Víctor Cervera-Carrascón, Markus Vähä‐Koskela, Sadia Zafar and Anu J. Airaksinen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Mikko Siurala

25 papers receiving 975 citations

Peers

Mikko Siurala

ONCOL

GENET

IMMUN

BIOTE

Riikka Havunen Finland

João M. Santos Finland

Suvi Sorsa Finland

Amanda Rosewell Shaw United States

Minna Oksanen Finland

Roshni Ravindranathan United States

Timo Joensuu Finland

Sari Pesonen Finland

Mari Hirvinen Finland

Padma Sampath United States

Riikka Havunen Finland

Mikko Siurala

934 ×1.1

ONCOL

753 ×1.1

GENET

375 ×1.1

335 ×1.1

IMMUN

223 ×1.1

BIOTE

Citations per year, relative to Mikko Siurala Mikko Siurala (= 1×) peers Riikka Havunen

Countries citing papers authored by Mikko Siurala

Since Specialization

Citations

This map shows the geographic impact of Mikko Siurala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Siurala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Siurala more than expected).

Fields of papers citing papers by Mikko Siurala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Siurala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Siurala. The network helps show where Mikko Siurala may publish in the future.

Co-authorship network of co-authors of Mikko Siurala

This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Siurala. A scholar is included among the top collaborators of Mikko Siurala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Siurala. Mikko Siurala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Castelli, Sofia, Uğur Uslu, Amanda Finck, et al.. (2023). 238 Potentiating CAR T cell therapy through synthetic IL-9R signaling. SHILAP Revista de lepidopterología. A274–A274. 1 indexed citations

Cervera-Carrascón, Víctor, Dafne C.A. Quixabeira, Riikka Havunen, et al.. (2020). Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors. Molecular Therapy — Oncolytics. 17. 47–60. 35 indexed citations

Santos, João M., Camilla Heiniö, Víctor Cervera-Carrascón, et al.. (2020). Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity. Journal for ImmunoTherapy of Cancer. 8(1). e000188–e000188. 56 indexed citations

Heiniö, Camilla, Riikka Havunen, Mikko Siurala, & Akseli Hemminki. (2020). Abstract A30: Molecular insight into pathogen-associated molecular pattern signaling during TNFa and IL2 armed oncolytic adenovirus treatments. Cancer Immunology Research. 8(4_Supplement). A30–A30. 1 indexed citations

Cervera-Carrascón, Víctor, Dafne C.A. Quixabeira, João M. Santos, et al.. (2020). Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition. OncoImmunology. 9(1). 1761229–1761229. 24 indexed citations

Heiniö, Camilla, Suvi Sorsa, Mikko Siurala, et al.. (2019). Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs. Human Gene Therapy. 30(6). 740–752. 2 indexed citations

Cervera-Carrascón, Víctor, Mikko Siurala, João M. Santos, et al.. (2018). TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade. OncoImmunology. 7(5). e1412902–e1412902. 90 indexed citations

Watanabe, Keisuke, Yanping Luo, Tong Da, et al.. (2018). Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 3(7). 215 indexed citations

Havunen, Riikka, João M. Santos, Suvi Sorsa, et al.. (2018). Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus. Molecular Therapy — Oncolytics. 11. 109–121. 45 indexed citations

10.

Santos, João M., Víctor Cervera-Carrascón, Riikka Havunen, et al.. (2018). Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy. Molecular Therapy. 26(9). 2243–2254. 44 indexed citations

11.

Havunen, Riikka, Mikko Siurala, Suvi Sorsa, et al.. (2017). Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy. Molecular Therapy — Oncolytics. 4. 77–86. 103 indexed citations

12.

Santos, João M., Riikka Havunen, Mikko Siurala, et al.. (2017). Adenoviral production of interleukin‐2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy. International Journal of Cancer. 141(7). 1458–1468. 18 indexed citations

13.

Siurala, Mikko, Riikka Havunen, Dipongkor Saha, et al.. (2016). Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma. Molecular Therapy. 24(8). 1435–1443. 43 indexed citations

14.

Watanabe, Keisuke, Sònia Guedan, John Scholler, et al.. (2016). Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells. Blood. 128(22). 3360–3360. 1 indexed citations

15.

Siurala, Mikko, Markus Vähä‐Koskela, Riikka Havunen, et al.. (2016). Syngeneic Syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting. OncoImmunology. 5(5). e1136046–e1136046. 16 indexed citations

16.

Tähtinen, Siri, Susanna Grönberg-Vähä-Koskela, Mikko Siurala, et al.. (2015). Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor. Cancer Immunology Research. 3(8). 915–925. 59 indexed citations

17.

Bramante, Simona, Anniina Koski, Ilkka Liikanen, et al.. (2015). Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer. OncoImmunology. 5(2). e1078057–e1078057. 36 indexed citations

18.

Tähtinen, Siri, Susanna Grönberg-Vähä-Koskela, Mikko Siurala, et al.. (2015). Combination immunotherapy with oncolytic adenovirus and adoptive T-cell transfer leads to systemic anti-tumor immunity and enhanced therapeutic efficacy in a preclinical melanoma model. Annals of Oncology. 26. viii5–viii5. 1 indexed citations

19.

Parviainen, Suvi, Iulia Diaconu, Anja Kipar, et al.. (2014). GMCSF‐armed vaccinia virus induces an antitumor immune response. International Journal of Cancer. 136(5). 1065–1072. 30 indexed citations

20.

Siurala, Mikko, Simona Bramante, Lotta Vassilev, et al.. (2014). Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma. International Journal of Cancer. 136(4). 945–954. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact